Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Programa de Inmunología
T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS‐CoV‐2 Vaccine Using Multiparametric Flow Cytometry
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description eji6020-sup-0001-SuppMat.pdf527.6 KB Supplementary File 1: eji6020-sup-0001-SuppMat.pdf References 1 , , , et al., “Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children,” Mbio 13, (2022): e0131122, https://doi.org/10.1128/mbio.01311-22.
Contribution of viral and bacterial infections to senescence and immunosenescence
1 Introduction Although the notion of senescence dates back to pre-historic ages, the concept of cellular senescence was described more recently in 1961 by Leonard Hayflick and Paul Moorhead while studying human fibroblasts (Hayflick and Moorhead, 1961). The principle was described as a stable state resulting from the exit of the cell-division cycle process, and characterized by a finite proliferative capacity of human fibroblasts in cultures (Hayflick and Moorhead, 1961; Hayflick, 1965).
Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development
1. Introduction Cholera is an acute, watery diarrheal disease caused by Vibrio cholerae, a curved, rod-shaped, motile, Gram-negative bacterium that lives in aquatic environments. Without prompt treatment, cholera can cause severe dehydration and death. Treatment involves administering saline oral rehydration solutions, intravenous fluids, or antibiotics, depending on the severity (1–3). V.
Frontiers | A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing Escherichia coli in mice
A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing Escherichia coli in mice David A. Montero1, 2, 3* , Richard Garcia-Betancourt2 , ROBERTO M. VIDAL4, 5 , Juliana Velasco6, Pablo A. Palacios2, Daniela Schneider2 , Carolina Vega7 , Leonardo Gómez3 , Hernan Montecinnos8 , Rodrigo Soto-Shara3 , Angel A. Oñate3 and Leandro J.
Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development
David A. Montero1, Roberto M. Vidal2, 3, Juliana Velasco4, Sergio George2, 5, Yalda Lucero2, Leonardo A. Gómez1, Leandro J.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Programa
Contact Programa, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack